Why is Clinitech Lab falling/rising?

As of 10-Sep, Clinitech Laboratory Ltd is currently priced at 51.00, reflecting a decrease of 0.78, or 1.51%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 6.42% during this period. Despite a recent 1-week return of 4.49% and a 1-month return of 17.76%, the year-to-date performance shows a significant decline of 35.33%. The stock's trading activity has been erratic, with no trades on one day out of the last 20 days. However, there has been a notable increase in investor participation, with delivery volume rising by 292.86% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors affecting the stock.
Broader market context indicates that while Clinitech Laboratory Ltd has outperformed the Sensex in the short term, its year-to-date performance is considerably worse than the benchmark, which has gained 4.21%. The stock's recent decline is compounded by its underperformance against the sector, where it lagged by 3.03%. The moving averages suggest mixed signals, as the stock is higher than the 20-day and 50-day moving averages but lower than the 5-day, 100-day, and 200-day moving averages, indicating potential volatility in its price movements.